The Journal of Nutrition, Health and Aging (Mar 2024)

The role of adiponectin in Alzheimer’s disease: A translational review

  • Louise Sindzingre,
  • Elodie Bouaziz-Amar,
  • François Mouton-Liger,
  • Emmanuel Cognat,
  • Julien Dumurgier,
  • Agathe Vrillon,
  • Claire Paquet,
  • Matthieu Lilamand

Journal volume & issue
Vol. 28, no. 3
p. 100166

Abstract

Read online

Adiponectin is an adipokine playing a central role in the regulation of energy homeostasis, carbohydrate and lipid metabolism, as well as immunomodulation. The relationship between Alzheimer’s disease (AD) and body composition has highlighted the bidirectional crosstalk between AD’s pathophysiology and metabolic disorders. This review aimed to report the current state of knowledge about cellular and molecular mechanisms linking adiponectin and AD, in preclinical studies. Then, we reviewed human studies to assess the relationship between adiponectin levels and AD diagnosis. We also examined the risk of incident AD regarding the participants’ baseline adiponectin level, as well as the relationship of adiponectin and cognitive decline in patients with AD.We conducted a systematic review, in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses reporting guideline, of studies published over the last decade on MEDLINE and Cochrane databases. Overall, we reviewed 34 original works about adiponectin in AD, including 11 preclinical studies, two both preclinical and human studies and 21 human studies. Preclinical studies brought convincing evidence for the neuroprotective role of adiponectin on several key mechanisms of AD. Human studies showed conflicting results regarding the relationship between AD and adiponectin levels, as well as regarding the cross-sectional association between cognitive function and adiponectin levels. Adiponectin did not appear as a predictor of incident AD, nor as a predictor of cognitive decline in patients with AD.Despite solid preclinical evidence suggesting the protective role of adiponectin in AD, inconsistent results in humans supports the need for further research.

Keywords